Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Insights on LRRK2, gene behind Parkinson’s disease

Natural killer cells: Defence against self-destruction

Arachnophobia Might Have Evolutionary Origins

Insights on LRRK2, gene behind Parkinson’s disease
  • BiotechToday
  • World

Insights on LRRK2, gene behind Parkinson’s disease

bioxone August 7, 2021August 6, 2021

Varuni Ankolekar, Quartesian

One of the common neurogenerative disorders noticed in elderly populations is Parkinson’s disease that affects movement. Common symptoms are tremor, rigidity, bradykinesia, and postural instability.

Gene behind Parkinson’s disease:

Dysfunction of the Leucine-rich repeat kinase 2 (LRRK2) gene on chromosome 12 has proven to be the cause of Parkinson’s disease. LRRK2 is a Kinase enzyme that is encoded by the LRRK2 gene. LRRK2 gene is widely expressed in the brain and other tissues all over the body. Both autosomal coding mutations and non-coding variations can be seen at the LRRK2 locus. The functional consequences of the non-coding variants are not clear. However, it plays a key factor in Parkinson’s as it indicates the physiological function of LRRK2.

Interpreting atomic-resolution structural data of LRRK2 was challenging due to its large size which is 250 kDa.

Structure of LRRK2:

LRRK2 is a large protein, made up of 2527 amino acids. It comprises several domains which have different functions. The structure of LRRK2 involves Ras of Complex (Roc) GTPase at the center along with the C-terminus of Roc (COR) domain after which serine-threonine kinase domains are observed. Several proteins -protein interactions are noticed with ankyrin and leucine-rich repeat motifs while WD40 repeats at the N-terminus and C-terminus respectively.

LRRK2 structure including individual domains and orthologous proteins:

  • In 2008, the structure of the ROC domain was studied in H. sapiens under 2.0 Å resolution using X-ray crystallography by purifying isolated domains and/or exploring orthologous proteins.
  • In 2008, the structure of ROC–COR was examined in C. tepidum under 2.90 Å resolution using X-ray crystallography.
  • In 2012, the structure of the Kinase domain isolated from D. discoidium was analyzed under 1.8 Å resolution using X-ray crystallography.
  • In 2016, the prototype for Full-length LRRK2 was suggested in H. sapiens and LRR in C. tepidum at 33 Å and 2.3 Å resolution with the help of CryoEM and X-ray crystallography respectively.
  • In 2017, the structure of Full length in H. sapiens at 24.2 Å resolution using CryoEM was performed.
  • In 2019, the model of ROC in H. sapiens at 1.6 Å resolution using X-ray crystallography
  • In 2019, the structure of WD40 in H. sapiens 2.6 Å resolution using X-ray crystallography
  • In 2019, the structure of LRR–ROC–COR in C. tepidum 3.29 Å resolution using X-ray crystallography. The study so far gave the understandings at the molecular level. However, the impact of mutations is yet to be known.
  • In 2020, the structure of ROC–COR–Kinase– WD40 in H. sapiens under 3.50 Å resolution using CryoEM.
  • In 2020, the structure of Full-length LRRK2 was proposed H. sapiens 14 Å resolution using CryoEM
  • Recently, in 2021, the structure of Full-length LRRK2 was proposed H. sapiens 3.7 Å for monomer and 3.5 Å resolution for a dimer using CryoEM which provided insights on the spatial relationship between LRRK2 domains.

The bottom line is the identification of LRRK2 structures as it has been of interest for several reasons. The recent discovery of full length has uncovered the complex LRRK2 interactions between the domains and gave a bit of clarification on mutations at LRRK2 kinase and LRRK2 ROC– COR domain. Further understandings of the connection between structure and function will be crucial to focus on Parkinson’s while studying the effect of various coding mutations and risk variants observed in LRRK2 associated with Parkinson’s disease.

Also read: HIV Drug Resistance prediction using in-silico methods!

Reference:

1. Herbst, S., & Lewis, P. A. (2021). From structure to ætiology: A new window on the biology of leucine-rich repeat kinase 2 and Parkinson’s disease. Biochemical Journal, 478(14), 2945–2951. https://doi.org/10.1042/BCJ20210383

2. Rui, Q., Ni, H., Li, D., Gao, R., & Chen, G. (2018). The role of lrrk2 in neurodegeneration of parkinson disease. Current Neuropharmacology, 16(9), 1348–1357. https://doi.org/10.2174/1570159X16666180222165418

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Author Info: Varuni Ankolekar, Quartesian

Publications:

  • https://bioxone.in/news/worldnews/artificial-sweeteners-after-effect-on-human-gut-health/
  • https://bioxone.in/news/worldnews/romanesco-cauliflower-its-spiraling-fractal-shape/
  • https://bioxone.in/news/worldnews/the-emergence-of-the-kappa-variant-of-sars-cov-2/
  • https://bioxone.in/news/worldnews/rosettafold-a-software-to-predict-protein-structures-using-deep-learning/

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged C-terminus CryoEM LRRK2 N-terminus neurogenerative disorders Parkinson’s disease X-ray crystallography

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Biotechnopedia
  • DNA-Tales

Arachnophobia Might Have Evolutionary Origins

DNA tales August 7, 2021

Diya Adhikary, Amity University Kolkata Have you ever experienced sudden fear on the sight of an eight-legged monster with fangs that’s crawling towards you? Yes I am talking about spiders. According to recent research, arachnophobia, or intense fear of spiders and spider webs can be a product of human evolution. Let us know how that […]

arachnophobia

Related Post

  • BiotechToday
  • World

Use of Nanoclusters in protecting precious Metals

BioTech Today August 31, 2021August 31, 2021

Nimrit Palan, Mumbai University A recent finding regarding nanoclusters has the potential to unlock the maximum capabilities of catalysis in chemistry, paving the way for new ways of making and using particles that are both atom-efficient and energy-resilient. What are nanoclusters? Metal nanoclusters are made up of a small number of atoms, usually in the […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Pfizer— coming to rescue from next week.

bioxone December 3, 2020December 3, 2020

Shrestha Dutta, Amity University Kolkata England affirmed Pfizer COVID-19 antibody on Wednesday, hoping in front of the United States and Europe to turn into the West’s first nation to officially embrace a hit it said should reach the most susceptible individuals early next week. PM Boris Johnson promoted the medication authority’s endorsement as a worldwide […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Engineered antibody: Potential cure to COVID – 19?

bioxone November 22, 2020November 22, 2020

Prama Ghosh, Amity University Kolkata The utilization of antibodies to battle human illness goes back to the 1890s and it is in practice even today. The blood plasma of patients who have recovered from COVID-19 contains antibodies against the SARS-CoV-2 virus which is called plasma therapy and used as a treatment for people with coronavirus […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy